OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

TKIs in combination with immunotherapy for hepatocellular carcinoma
Bernardo Stefanini, Luca Ielasi, Rusi Chen, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 3, pp. 279-291
Closed Access | Times Cited: 87

Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 41

Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures
Bokyung Ahn, Hee‐Sung Ahn, Jin-Ho Shin, et al.
Liver International (2024) Vol. 44, Iss. 5, pp. 1202-1218
Open Access | Times Cited: 6

Telomere-related prognostic biomarkers for survival assessments in pancreatic cancer
Shengyang Chen, Shuiquan Hu, Zhou Baizhong, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13

Identification of a Cancer Stem Cell-Related Gene Signature in Hepatocellular Carcinoma Based on Single-Cell RNA-Seq and Bulk RNA-Seq Analysis
Jing Wu, Xu Liu, Sheng Huang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2933-2933
Open Access

Construction of a tumor immune microenvironment-related risk scoring model for prognosis of hepatocellular carcinoma
Xinyi Li, Zhaohui Qin, Haozhi Chen, et al.
International Journal of Immunopathology and Pharmacology (2025) Vol. 39
Open Access

Identification of VRK1 as a Novel Potential Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
Xiaoyan He, Guozhen Zai, Lidan Zhou, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 1671-1683
Open Access | Times Cited: 3

Lysosome-Related Diagnostic Biomarkers for Pediatric Sepsis Integrated by Machine Learning
Yang Yang, Genhao Zhang
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5575-5583
Open Access | Times Cited: 4

Predictive Value of a Diagnostic Five-Gene Biomarker for Pediatric Sepsis
Yulong Xiao, Genhao Zhang
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2063-2071
Open Access | Times Cited: 1

Basement membrane-related regulators for prediction of prognoses and responses to diverse therapies in hepatocellular carcinoma
Ruili Ding, Chuanbing Zhao, Yixin Jing, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 3

Genes Modulating Butyrate Metabolism for Assessing Clinical Prognosis and Responses to Systematic Therapies in Hepatocellular Carcinoma
Chuanbing Zhao, Zhengle Zhang, Ruili Ding, et al.
Biomolecules (2022) Vol. 13, Iss. 1, pp. 52-52
Open Access | Times Cited: 4

Comprehensive multi-omics analysis identifies NUSAP1 as a potential prognostic and immunotherapeutic marker for lung adenocarcinoma
Jun Ma, Wenjing Zhu, Ran Zhou, et al.
International Journal of Medical Sciences (2024) Vol. 22, Iss. 2, pp. 328-340
Open Access

Prognostic Lysosome-Related Biomarkers for Predicting Drug Candidates in Hepatocellular Carcinoma: An Insilco Analysis
Junxiu Xu, Kai Zhang, Genhao Zhang
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 459-472
Open Access | Times Cited: 1

Development of a tumor microenvironment‐related prognostic signature in glioma to predict immune landscape and potential therapeutic drugs
Yang Zhang, Chunmiao Wu, Qiang Li, et al.
Journal of Biochemical and Molecular Toxicology (2023)
Closed Access

Page 1

Scroll to top